Select Medical Holdings Corp
SEM14.770USD
-0.070-0.47%
Cierre 12/26, 16:00（ET）Cotizaciones retrasadas 15 min
1.83BCap. mercado
16.90P/E TTM
Más Datos de Select Medical Holdings Corp Compañía
Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 104 critical illness recovery hospitals in 29 states, 35 rehabilitation hospitals in 14 states, and 1,914 outpatient rehabilitation clinics in 39 states and the District of Columbia.
Información de Select Medical Holdings Corp
Símbolo de cotizaciónSEM
Nombre de la empresaSelect Medical Holdings Corp
Fecha de salida a bolsaSep 25, 2009
Director ejecutivoMullin (Thomas P)
Número de empleados30000
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 25
DirecciónC/O Select Medical Corp
CiudadMECHANICSBURG
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal17055
Teléfono17179721100
Sitio Webhttps://www.selectmedical.com/
Símbolo de cotizaciónSEM
Fecha de salida a bolsaSep 25, 2009
Director ejecutivoMullin (Thomas P)
Ejecutivos de Select Medical Holdings Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
9.93M
+7.96%
Mr. Martin F. Jackson
Mr. Martin F. Jackson
Senior Executive Vice President of Strategic Finance and Operations
Senior Executive Vice President of Strategic Finance and Operations
1.38M
-0.76%
Mr. David S. Chernow
Mr. David S. Chernow
Vice Chairman of the Board
Vice Chairman of the Board
892.83K
-5.21%
Mr. Russell L. Carson
Mr. Russell L. Carson
Lead Independent Director
Lead Independent Director
610.03K
+2.35%
Mr. Thomas P. (Tom) Mullin
Mr. Thomas P. (Tom) Mullin
Chief Executive Officer
Chief Executive Officer
391.71K
-5.33%
Mr. Brian R. Rusignuolo
Mr. Brian R. Rusignuolo
Executive Vice President, Chief Information Officer
Executive Vice President, Chief Information Officer
361.37K
-3.90%
Mr. Michael F. Malatesta
Mr. Michael F. Malatesta
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
238.06K
-3.00%
Mr. Thomas A. (Tom) Scully, J.D.
Mr. Thomas A. (Tom) Scully, J.D.
Independent Director
Independent Director
89.39K
+12.60%
Dr. Parvinderjit Singh Khanuja
Dr. Parvinderjit Singh Khanuja
Independent Director
Independent Director
79.12K
+21.56%
Ms. Katherine R. Davisson
Ms. Katherine R. Davisson
Independent Director
Independent Director
60.03K
+30.51%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
9.93M
+7.96%
Mr. Martin F. Jackson
Mr. Martin F. Jackson
Senior Executive Vice President of Strategic Finance and Operations
Senior Executive Vice President of Strategic Finance and Operations
1.38M
-0.76%
Mr. David S. Chernow
Mr. David S. Chernow
Vice Chairman of the Board
Vice Chairman of the Board
892.83K
-5.21%
Mr. Russell L. Carson
Mr. Russell L. Carson
Lead Independent Director
Lead Independent Director
610.03K
+2.35%
Mr. Thomas P. (Tom) Mullin
Mr. Thomas P. (Tom) Mullin
Chief Executive Officer
Chief Executive Officer
391.71K
-5.33%
Mr. Brian R. Rusignuolo
Mr. Brian R. Rusignuolo
Executive Vice President, Chief Information Officer
Executive Vice President, Chief Information Officer
361.37K
-3.90%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Non-Medicar
826.30M
61.68%
Medicare
381.56M
28.48%
Other
97.08M
7.25%
Other revenues
34.64M
2.59%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Non-Medicar
826.30M
61.68%
Medicare
381.56M
28.48%
Other
97.08M
7.25%
Other revenues
34.64M
2.59%
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
12.96%
T. Rowe Price Associates, Inc.
12.75%
The Vanguard Group, Inc.
10.13%
Ortenzio (Robert A)
8.02%
Dimensional Fund Advisors, L.P.
4.20%
Otro
51.93%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
12.96%
T. Rowe Price Associates, Inc.
12.75%
The Vanguard Group, Inc.
10.13%
Ortenzio (Robert A)
8.02%
Dimensional Fund Advisors, L.P.
4.20%
Otro
51.93%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
52.57%
Investment Advisor/Hedge Fund
18.21%
Individual Investor
16.10%
Hedge Fund
7.29%
Research Firm
2.78%
Pension Fund
1.25%
Bank and Trust
0.54%
Sovereign Wealth Fund
0.19%
Insurance Company
0.03%
Otro
1.04%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
584
101.41M
81.89%
-13.28M
2025Q2
593
128.59M
103.28%
-15.30M
2025Q1
613
130.41M
101.46%
-13.79M
2024Q4
596
127.65M
98.98%
-7.70M
2024Q3
574
125.33M
96.47%
-2.82M
2024Q2
559
125.84M
96.80%
-1.37M
2024Q1
555
124.62M
97.09%
-1.67M
2023Q4
554
125.18M
97.72%
-2.54M
2023Q3
563
124.92M
98.22%
-6.02M
2023Q2
572
126.44M
99.43%
-8.51M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
15.99M
12.9%
-497.15K
-3.01%
Jun 30, 2025
T. Rowe Price Associates, Inc.
16.02M
12.92%
-1.05M
-6.17%
Jun 30, 2025
The Vanguard Group, Inc.
12.90M
10.4%
-377.96K
-2.85%
Jun 30, 2025
Ortenzio (Robert A)
9.20M
7.42%
+250.00K
+2.79%
Jul 29, 2025
Dimensional Fund Advisors, L.P.
4.99M
4.02%
+773.73K
+18.35%
Jun 30, 2025
State Street Investment Management (US)
4.25M
3.43%
+55.69K
+1.33%
Jun 30, 2025
Rocco A. Ortenzio UEO
4.09M
3.3%
-3.80M
-48.22%
Dec 31, 2024
Geode Capital Management, L.L.C.
3.04M
2.45%
+80.42K
+2.72%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
3.60M
2.9%
-429.17K
-10.65%
Jun 30, 2025
Principal Global Investors (Equity)
2.92M
2.36%
+447.99K
+18.09%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
State Street SPDR S&P Health Care Services ETF
2.26%
Invesco S&P SmallCap Value with Momentum ETF
0.98%
Invesco S&P SmallCap Health Care ETF
0.94%
Invesco S&P SmallCap High Dividend Low Volatility ETF
0.77%
First Trust Small Cap Value AlphaDEX Fund
0.71%
WisdomTree US SmallCap Quality Dividend Growth
0.71%
Invesco S&P SmallCap 600 Pure Value ETF
0.66%
Invesco S&P SmallCap 600 Revenue ETF
0.52%
Invesco Zacks Multi-Asset Income ETF
0.42%
Invesco S&P SmallCap Quality ETF
0.42%
Ver más
State Street SPDR S&P Health Care Services ETF
Proporción2.26%
Invesco S&P SmallCap Value with Momentum ETF
Proporción0.98%
Invesco S&P SmallCap Health Care ETF
Proporción0.94%
Invesco S&P SmallCap High Dividend Low Volatility ETF
Proporción0.77%
First Trust Small Cap Value AlphaDEX Fund
Proporción0.71%
WisdomTree US SmallCap Quality Dividend Growth
Proporción0.71%
Invesco S&P SmallCap 600 Pure Value ETF
Proporción0.66%
Invesco S&P SmallCap 600 Revenue ETF
Proporción0.52%
Invesco Zacks Multi-Asset Income ETF
Proporción0.42%
Invesco S&P SmallCap Quality ETF
Proporción0.42%
Dividendos
Un total de
243.71M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Oct 30, 2025
SEM.NB Final Cash Dividend of gross USD 0.0625 paid on Nov 25, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 25, 2025
Nov 12, 2025
Jul 31, 2025
SEM.NB Interim Cash Dividend of gross USD 0.0625 paid on Aug 28, 2025 going ex on Aug 13, 2025
Aug 13, 2025
Aug 28, 2025
Aug 13, 2025
May 01, 2025
SEM.NB Interim Cash Dividend of gross USD 0.0625 paid on May 29, 2025 going ex on May 15, 2025
May 15, 2025
May 29, 2025
May 15, 2025
Feb 20, 2025
SEM.NB Interim Cash Dividend of gross USD 0.0625 paid on Mar 13, 2025 going ex on Mar 03, 2025
Mar 03, 2025
Mar 13, 2025
Mar 03, 2025
Oct 31, 2024
SEM.NB Final Cash Dividend of gross USD 0.125 paid on Nov 26, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 26, 2024
Nov 13, 2024
Aug 01, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Aug 30, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 30, 2024
Aug 14, 2024
May 02, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on May 30, 2024 going ex on May 15, 2024
May 16, 2024
May 30, 2024
May 15, 2024
Feb 22, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Mar 13, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 13, 2024
Feb 29, 2024
Nov 02, 2023
SEM.NB Final Cash Dividend of gross USD 0.125 paid on Nov 28, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Nov 28, 2023
Nov 14, 2023
Aug 03, 2023
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Sep 01, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 01, 2023
Aug 14, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Select Medical Holdings Corp?
Los cinco principales accionistas de Select Medical Holdings Corp son:
BlackRock Institutional Trust Company, N.A. posee 15.99M acciones, lo que representa el 12.90% del total de acciones.
T. Rowe Price Associates, Inc. posee 16.02M acciones, lo que representa el 12.92% del total de acciones.
The Vanguard Group, Inc. posee 12.90M acciones, lo que representa el 10.40% del total de acciones.
Ortenzio (Robert A) posee 9.20M acciones, lo que representa el 7.42% del total de acciones.
Dimensional Fund Advisors, L.P. posee 4.99M acciones, lo que representa el 4.02% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 15.99M acciones, lo que representa el 12.90% del total de acciones.
T. Rowe Price Associates, Inc. posee 16.02M acciones, lo que representa el 12.92% del total de acciones.
The Vanguard Group, Inc. posee 12.90M acciones, lo que representa el 10.40% del total de acciones.
Ortenzio (Robert A) posee 9.20M acciones, lo que representa el 7.42% del total de acciones.
Dimensional Fund Advisors, L.P. posee 4.99M acciones, lo que representa el 4.02% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Select Medical Holdings Corp?
Los tres principales tipos de accionista de Select Medical Holdings Corp son:
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
¿Cuántas instituciones poseen acciones de Select Medical Holdings Corp (SEM)?
A fecha de 2025Q3, 584 instituciones poseen acciones de Select Medical Holdings Corp, con un valor de mercado combinado de aproximadamente 101.41M, lo que representa el 81.89% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -21.39%.
¿Cuál es la mayor fuente de ganancias de Select Medical Holdings Corp?
El FY2025Q2, el segmento empresarial Non-Medicar generó la ganancia más alta para Select Medical Holdings Corp, ascendiendo a 826.30M y representando el 61.68% de la ganancia total.
